Search - tctmd.com

Displaying 241 - 260 of 624

Sort: Relevancy | Date

Presentation TVT 2022

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Presenter: Brian Whisenant

June 08, 2022

Presentation TVT 2022

Perspective 1: Targeting the Leaflets Will Be Enough – Future Generation TEER Technologies Will Have It All!

Presenter: D. Scott Lim

June 08, 2022

Presentation TVT 2022

Potential Solutions: Alternative TMVr Concepts – Annuloplasty and Chordal Replacement Technologies

Presenter: Scott Lim

June 08, 2022

Presentation TVT 2022

My Biggest TMVr Frustration: Achieving Consistent and Predictable Results in the “Real World”

Presenter: Paul Sorajja

June 08, 2022

Presentation TVT 2022

Innovation in TMVr: Lessons Learned From the Surgeons

Presenter: Thomas Modine

June 08, 2022

News Conference News EuroPCR 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

Yael L. Maxwell

May 19, 2022

News Conference News EuroPCR 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Michael O'Riordan

May 19, 2022

News Features

As TAVI Turns 20, How Has the Heart Team Evolved?

Yael L. Maxwell

May 04, 2022

News Daily News

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Caitlin E. Cox

March 08, 2022

Presentation Miami Valves 2022

Transcatheter Mitral Valve Indirect Annuloplasty Repair for Functional Mitral Regurgitation

Presenter: Adithya Mathews

February 04, 2022

News Conference News STS 2022

CHOICE-MI: TMVR Mortality Much Lower With Newer Transseptal Devices

Todd Neale

February 03, 2022

News Conference News STS 2022

Modified Surgical MV Repair Stands Up to Replacement

Michael O'Riordan

February 03, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Conference News PCR London Valves 2021

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

Shelley Wood

November 26, 2021

News Conference News PCR London Valves 2021

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Michael O'Riordan

November 25, 2021

News Conference News PCR London Valves 2021

Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry

Shelley Wood

November 24, 2021

News Conference News AHA 2021

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

Caitlin E. Cox

November 13, 2021

News Conference News TCT 2021

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Yael L. Maxwell

November 06, 2021

Presentation TCT 2021

Limitations of TEER and Justification for Additional Transcatheter Repair Concepts

Presenter: Georg Nickenig

November 05, 2021

Presentation TCT 2021

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Presenter: Ori Ben-Yehuda

November 05, 2021

Advertisement

Perspective 2: Annular Reduction Will Usually Be Needed, Stand-Alone or Complementing TEER!

Perspective 1: Targeting the Leaflets Will Be Enough – Future Generation TEER Technologies Will Have It All!

Potential Solutions: Alternative TMVr Concepts – Annuloplasty and Chordal Replacement Technologies

My Biggest TMVr Frustration: Achieving Consistent and Predictable Results in the “Real World”

Innovation in TMVr: Lessons Learned From the Surgeons

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

As TAVI Turns 20, How Has the Heart Team Evolved?

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

Transcatheter Mitral Valve Indirect Annuloplasty Repair for Functional Mitral Regurgitation

CHOICE-MI: TMVR Mortality Much Lower With Newer Transseptal Devices

Modified Surgical MV Repair Stands Up to Replacement

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI

Promising Early Results for TriClip in Tricuspid Regurgitation: bRIGHT Registry

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward

Limitations of TEER and Justification for Additional Transcatheter Repair Concepts

Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content